Evonik opens new facility for pharmaceutical lipids in Germany
Evonik has opened a new GMP facility to manufacture lipids for advanced pharmaceutical drug delivery applications, which is situated at the company’s site in Hanau, Germany.
Archives for March 9, 2023
Recipharm’s Arranta Bio expands RNA process development capacity by 50%
Arranta Bio, a Recipharm company, has doubled capacity at its Massachusetts facility for process development services supporting RNA therapeutics.
Sandoz to build new biologics production plant in Slovenia, facility will support global demand for biosimilars
Sandoz is set to build a new biologics production plant in Lendava, Slovenia.
Merck teams up with ModeX Therapeutics to develop an Epstein-Barr Virus vaccine
OPKO Health’s ModeX Therapeutics has entered into an exclusive worldwide license and collaboration agreement with Merck to develop MDX-2201, ModeX’s preclinical nanoparticle vaccine candidate targeting EBV.